SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novoste (novt)
NOVT 111.14-6.6%Jan 2 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TwoBear who wrote (94)9/15/2001 5:49:18 PM
From: Oak Tree   of 100
 
Looks like the rapamycin stent killed the NOVT stock price. THe NOVT system works however the company has a net cumulative loss per share of about $2 (or about $650MM). Even thought the price looks low here it could easily go further south especially since 38% of the shares are in the hads of insiders that are likely to want to get out soon (like Monday)

<<Insiders own 38%. Pilgrim Baxter owns 7%, Putnam Investments  owns 6%.>>

Might come back in however if it survives the crash.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News